Changes in oestrogen receptor-alpha and -beta during progression to acquired resistance to tamoxifen and fulvestrant (Faslodex, ICI 182,780) in MCF7 human breast cancer cells.

Source:http://linkedlifedata.com/resource/pubmed/id/16533599

Download in:

View as

General Info

PMID
16533599